AIMD: Ainos Projected Price to Earnings

AIMD (Ainos, Inc.) - company brandmark

Concentration risks in AI diagnostics for Ainos, Inc. (AIMD) are mitigated by licensing and expansion in the US. Internal processes rely on proprietary R&D while equipment production is outsourced. The company's expected NTM P/E reflects the impact of its strategy to integrate rapid tests into telemedicine, where the 0.00 indicator determines the metric's magnitude, helping investors identify asset overheating phases.

Market Cap to Projected Earnings: ainos.com (AIMD) for 04/28/2023 - 11/15/2026

Analytical breakdowns and data insights for company Ainos, Inc. (AIMD)

- stock value and consensus price forecast:
- market capitalization information:
Comprehensive company analysis:Ainos Corporation
Signature product of Ainos Corporation

Volatility in the value of Ainos, Inc. (AIMD) within the Point-of-Care diagnostics segment requires monitoring via the ratio of market price to expected earnings, which allows for the prompt identification of asset overvaluation. As portable breath analyzers expand into clinics, the company's forward P/E valuation transforms static forecasts into a dynamic trend, helping investors determine a fair entry point based on the business's future profitability.

Main competitors

Forward P/E Multiple A|DGX - Projected Price to Earnings Ratio|Illumina Inc - Projected Price to Earnings|exactsciences.com (EXAS) - Projected Price to Earnings Ratio|RVTY - Future Price to Earnings|Market Cap to Projected Earnings Bio-Rad Laboratories, Inc. BIO|NNNN: Forward P/E Multiple|SHC - Market Cap to Projected Earnings|Future Price to Earnings quidel.com|Projected Price to Earnings Ratio opko.com OPK|Forward P/E Multiple CDNA|Projected Price to Earnings Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc - Projected Price to Earnings|Forward P/E Multiple Standard BioTools Corp LAB|CTKB: Projected Price to Earnings|OSUR - Forward P/E Multiple|XGN: Forward P/E Multiple|MDxHealth - Future Price to Earnings Multiple|LUCD (Lucid Diagnostics Inc.) - Forward P/E Multiple|PRE (Prenetics Global) - Market Cap to Future Earnings Ratio|Forward P/E Multiple IMDX|Market Cap to Future Earnings Ratio TRIB|Future Price to Earnings ProPhase Labs Inc PRPH|Forward Price to Earnings Multiple Co-Diagnostics Inc|heartsciences.com - Forward P/E Multiple|Biomerica, Inc (BMRA) - Projected Price to Earnings|CDIO: Forward P/E Multiple|Price to Future Earnings Ratio ONCO|Future Price to Earnings Virax Biolabs|Bluejay Diagnostics, Inc. (BJDX) - Market Cap to Projected Earnings|Future Price to Earnings Aspira Women's Health (AWH)|AXDX (Accelerate Diagnostics, Inc) - Future Price to Earnings Multiple|CENTOGENE, N.V. - Projected Price to Earnings|Future Price to Earnings Multiple ENZ|Future Price to Earnings Multiple fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Price to Future Earnings Ratio|ME: Forward P/E Multiple|Price to Future Earnings Ratio PMD